We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
+45.04%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$170M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
84.34%
Top 10 Holdings %
Top 10 Hldgs %
92.94%
Holding
21
New
21
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$24.8M |
| 2 |
Natera
NTRA
|
+$23.8M |
| 3 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$16.6M |
| 4 |
Guardant Health
GH
|
+$16.2M |
| 5 |
Adaptive Biotechnologies
ADPT
|
+$10.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.82% |
| 2 | Materials | 7.58% |
| 3 | Technology | 1.27% |
| 4 | Miscellaneous | 0.4% |
| 5 | Consumer Discretionary | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
CareDx
CDNA
$3.47B
| $31M | 18.18% |
+427,500
| New | +$24.8M |
2020 Q4
0 quarters
|
|
|
2
Natera
NTRA
$59.1B
| $28.3M | 16.64% |
+284,801
| New | +$23.8M |
2020 Q4
0 quarters
|
|
|
3
Guardant Health
GH
$23.9B
| $18.2M | 10.66% |
+140,900
| New | +$16.2M |
2020 Q4
0 quarters
|
|
|
CELL
4
DELISTED
PhenomeX Inc. Common Stock
CELL
| $17.7M | 10.36% |
+197,477
| New | +$16.6M |
2020 Q4
0 quarters
|
|
|
AMRS
5
DELISTED
Amyris Inc.
AMRS
| $12.9M | 7.58% |
+2,092,216
| New | +$6.69M |
2020 Q4
0 quarters
|
|
|
6
Adaptive Biotechnologies
ADPT
$4.52B
| $12.3M | 7.22% |
+208,100
| New | +$10.7M |
2020 Q4
0 quarters
|
|
7
Illumina
ILMN
$41.2B
| $10.9M | 6.38% |
+30,223
| New | +$9.63M |
2020 Q4
0 quarters
|
|
8
Twist Bioscience
TWST
$12.5B
| $10.3M | 6.07% |
+73,178
| New | +$8.12M |
2020 Q4
0 quarters
|
|
|
EXAS
9
DELISTED
Exact Sciences
EXAS
| $9.97M | 5.85% |
+75,250
| New | +$9.1M |
2020 Q4
0 quarters
|
|
|
GNMK
10
DELISTED
GenMark Diagnostics, Inc
GNMK
| $6.81M | 4% |
+466,337
| New | +$6.18M |
2020 Q4
0 quarters
|
|
11
Thermo Fisher Scientific
TMO
$242B
| $6.8M | 3.99% |
+14,600
| New | +$6.85M |
2020 Q4
0 quarters
|
|
12
Sprott Physical Gold
PHYS
$14.8B
| $688K | 0.4% |
+45,626
| New | +$678K |
2020 Q4
0 quarters
|
|
13
Amazon
AMZN
$2.71T
| $651K | 0.38% |
+4,000
| New | +$638K |
2020 Q4
0 quarters
|
|
14
Microsoft
MSFT
$3.84T
| $606K | 0.36% |
+2,726
| New | +$586K |
2020 Q4
0 quarters
|
|
15
Adobe
ADBE
$94.5B
| $547K | 0.32% |
+1,094
| New | +$529K |
2020 Q4
0 quarters
|
|
16
Alphabet (Google) Class A
GOOGL
$4.2T
| $535K | 0.31% |
+6,100
| New | +$513K |
2020 Q4
0 quarters
|
|
17
Apple
AAPL
$4.87T
| $531K | 0.31% |
+4,000
| New | +$481K |
2020 Q4
0 quarters
|
|
18
NVIDIA
NVDA
$5.65T
| $474K | 0.28% |
+36,280
| New | +$486K |
2020 Q4
0 quarters
|
|
19
Stryker
SYK
$106B
| $441K | 0.26% |
+1,800
| New | +$408K |
2020 Q4
0 quarters
|
|
20
Visa
V
$677B
| $396K | 0.23% |
+1,809
| New | +$370K |
2020 Q4
0 quarters
|
|
21
Intuitive Surgical
ISRG
$138B
| $360K | 0.21% |
+1,320
| New | +$328K |
2020 Q4
0 quarters
|
|
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Blue Water Life Science Advisors, which disclosed 21 positions worth $170M. Its ten largest holdings account for 93% of the portfolio.
Its largest position is CareDx: 427,500 shares worth $31M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Materials and Technology.
- Blue Water Life Science Advisors's largest Q4 2020 buy was CareDx: 427,500 shares worth $31M.
- Blue Water Life Science Advisors's ten largest holdings make up 93% of its $170M portfolio in Q4 2020.
- Blue Water Life Science Advisors disclosed 21 positions in Q4 2020, its first 13F filing on record.
Based on Blue Water Life Science Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.